Microangiopathy in multiple myeloma: a case of carfilzomib-induced secondary thrombotic microangiopathy successfully treated with plasma exchange and complement inhibition

Abstract Background Thrombotic microangiopathy (TMA) is a potentially organ and life-threatening condition affecting patients with multiple myeloma (MM). Cases of proteasome inhibitor-induced TMA and specifically carfilzomib-induced TMA have been rarely reported and standards for diagnostic workup a...

Full description

Bibliographic Details

Published in:	BMC Nephrology
Main Authors:	Lorenzo Catanese, Katharina Link, Harald Rupprecht
Format:	Article
Language:	English
Published:	BMC 2023-06-01
Subjects:	Case report Thrombotic microangiopathy (TMA) Multiple myeloma (MM) Carfilzomib Eculizumab
Online Access:	https://doi.org/10.1186/s12882-023-03228-9